Genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
increasingly important to monitor the transmission and adaptive evolution of the virus. The …

Background The mutational landscape of SARS-CoV-2 varies at the dominant viral genome
sequence and minor genomic variant population. During the COVID-19 pandemic, an early …

COVID-19 is a complex disease phenotype where the underlying microbiome could influence
morbidity and mortality. Amplicon and metagenomic MinION based sequencing was used …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019 (COVID-19). Sequencing the viral genome as the outbreak …

Background: the nephrotoxicity of methotrexate (MTX) is observed in high-dose therapy.
Moreover, low-dose MTX therapy for rheumatic diseases is debatable and claimed to cause …

SARS-CoV-2 emerged in the human population in late 2019, and human-to-human transmission
has dominated the evolutionary landscape and driven the selection of different lineages…

Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection that
emerged in the Middle East in 2012. Symptoms range from mild to severe and include both …

SARS-CoV-2 emerged into the human population in late 2019 and human to human
transmission has dominated the evolutionary landscape and driven the selection of different …

The current research aimed to evaluate the hospitalized COVID-19 Patients’ characteristics,
comorbidities, and outcomes. The present hospital-based study was executed in the COVID-…

Middle East Respiratory Syndrome coronavirus (MERS-CoV) is a zoonotic infection that
emerged in the Middle East in 2012. Symptoms range from mild to severe and include both …